US NIH launches long-COVID trials of Pfizer's Paxlovid, other therapies

Indonesia Berita Berita

US NIH launches long-COVID trials of Pfizer's Paxlovid, other therapies
Indonesia Berita Terbaru,Indonesia Berita utama
  • 📰 Reuters
  • ⏱ Reading Time:
  • 31 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 97%

The U.S. National Institutes of Health (NIH) said on Monday that it had launched mid-stage clinical trials to test at least four treatments, including Pfizer's Paxlovid, in patients with symptoms of long COVID.

July 31 - The U.S. National Institutes of Health said on Monday that it had launched mid-stage clinical trials to test at least four treatments, including Pfizer'sThe studies are designed to evaluate multiple therapies, where the first part of trial will test a longer dosing regimen of the antiviral COVID-19 drug Paxlovid to see if it improves long COVID symptoms.

The complex medical condition involves more than 200 symptoms ranging from exhaustion and cognitive impairment to pain, fever and heart palpitations that can last for months and even years following a COVID-19 infection.It will use medical treatments like a web-based brain training program called BrainHQ by San Franscisco-based private company Posit Science Corp and Soterix Medical Inc's device that uses a small electric current to stimulate brain activity, the health agency added.

Additional clinical trials are expected to be launched to test not less than seven more treatments, it said.

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

Reuters /  🏆 2. in US

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

Virus remains Biden focus as NIH launches long COVID trialsVirus remains Biden focus as NIH launches long COVID trialsThe National Institutes of Health on Monday said it’s launching trials to test drugs and other treatments for long COVID, a mysterious condition that affects millions of people after they catch the coronavirus.
Baca lebih lajut »

PolitiFact - Pfizer facility destroyed by tornado didn’t manufacture COVID-19 vaccinesPolitiFact - Pfizer facility destroyed by tornado didn’t manufacture COVID-19 vaccinesAfter a tornado struck a Pfizer facility on July 19 in North Carolina, some social media users claimed the company’s COVID-19 vaccine supply had been demolished. But Pfizer said this facility did not manufacture or store COVID-19 vaccines.
Baca lebih lajut »

Oh Jung Se Postpones “Revenant” Interviews After Testing Positive For COVID-19Oh Jung Se Postpones “Revenant” Interviews After Testing Positive For COVID-19OhJungSe Postpones 'Revenant' Interviews After Testing Positive For COVID-19
Baca lebih lajut »

Murray Mandryk: COVID-19 inquiry may explain why we can't pull togetherMurray Mandryk: COVID-19 inquiry may explain why we can't pull togetherWe used to be pretty good in this country at coming together in a crisis ... or so it seemed. skpoli
Baca lebih lajut »

Federal government struggling to get rid of millions of extra COVID-19 rapid testsFederal government struggling to get rid of millions of extra COVID-19 rapid testsThe federal government is sitting on a stockpile of 39 million extra rapid tests for COVID-19 and is struggling to get rid of them without chucking them in the trash. cdnpoli
Baca lebih lajut »

Rand Paul announces 'official criminal referral,' claims email shows Fauci COVID testimony 'absolutely a lie'Rand Paul announces 'official criminal referral,' claims email shows Fauci COVID testimony 'absolutely a lie'Sen. Rand Paul, R-Ky., said a newly unredacted email 'directly contradicts' Dr. Anthony Fauci's testimony about COVID-19 gain-of-function research.
Baca lebih lajut »



Render Time: 2025-03-10 05:58:41